Compare ADMA Biologics Inc (ADMA) vs Comfort Systems USA Inc (FIX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ADMA Biologics Inc vs Comfort Systems USA Inc — how do they compare? ADMA Biologics Inc trades at $9.23 (market cap $2.13B), while Comfort Systems USA Inc trades at $1,655 (market cap $59.26B). The key difference: Comfort Systems USA Inc is far larger — about 27.8× ADMA Biologics Inc's market cap, and Comfort Systems USA Inc pays a 0.15% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | FIX | |
|---|---|---|
Market Cap | $2.13B | $59.26B |
Sector | Health | Technology |
52-Week High | $20.38 | $2.07K |
52-Week Low | $7.60 | $527.42 |
Enterprise Value | $2.20B | $58.55B |
Dividend Yield | — | 0.15% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.
The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.
Comfort Systems USA (FIX) trades at $1,793.03, up 2.97% with strong earnings momentum as Q1 2026 EPS of $10.51 beat expectations of $6.81. The stock shows bearish technical signals but maintains robust fundamentals with 2025 revenue of $9.10B and net income of $1.02B. Recent news highlights leadership transitions and data center cooling demand driving growth.
Outlook remains positive with analyst consensus price target of $2,080 representing 16% upside potential. Key risks include execution challenges from record backlog and competitive pressures in HVAC infrastructure. The company's strong cash flow generation supports dividend payments and strategic acquisitions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Comfort Systems USA Inc
Comfort Systems USA is a premier provider of mechanical and electrical contracting services. It specializes in HVAC, plumbing, and energy management solutions for commercial and industrial facilities.
Read more on FIX →
